Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 407 followers
Latest posts
Last updated 8 minutes ago
Clinical Success Is No Longer One Number
8 minutes ago
In biopharmaceutical R&D, where fewer than 1 in 10 development programs ultimately...
Decision readiness is the next AI advantage
39 minutes ago
As AI raises the stakes, leaders need more than data. They need...
BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
about 4 hours ago
BioNTech is on the verge of returning to its oncology roots with...
AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
about 6 hours ago
The surprising failure of AstraZeneca and Ionis in a key phase 3...
In compensation push, HHS gears up to draft COVID vaccine injury table
about 7 hours ago
Aiming to streamline the compensation process for people claiming harm from COVID-19...
Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
about 7 hours ago
In a first for the neurotoxin market, Ipsen announced Thursday that its...
Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
about 9 hours ago
Novo Nordisk is running an exhibition in central London designed to start...
Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
about 9 hours ago
When launching a drug as big as semaglutide, even as a generic...
Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
about 9 hours ago
On the heels of a European Commission probe into whether Sanofi “disparaged”...
FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
about 16 hours ago
The FDA took issue with multiple claims describing Vyepti's efficacy listed on...
FDA halts release of new drug rejection letters while working to formalize policy
1 day ago
The FDA has paused a controversial policy of releasing letters describing its...
CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
1 day ago
CureDuchenne's "A Cure Can't Wait" serves as a public service announcement reminding...